Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Cerilliant
Healthtrust
Merck
Queensland Health
Harvard Business School
Covington
McKesson

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205122

« Back to Dashboard

NDA 205122 describes QUDEXY XR, which is a drug marketed by Upsher-smith Labs and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the QUDEXY XR profile page.

The generic ingredient in QUDEXY XR is topiramate. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the topiramate profile page.
Summary for 205122
Tradename:QUDEXY XR
Applicant:Upsher-smith Labs
Ingredient:topiramate
Patents:4
Therapeutic Class:Anticonvulsants
Antimigraine Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 205122
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122 NDA Upsher-Smith Laboratories, Inc. 0245-1071 N 0245-1071-30
QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122 NDA Upsher-Smith Laboratories, Inc. 0245-1071 N 0245-1071-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength25MG
Approval Date:Mar 11, 2014TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Mar 19, 2033Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 19, 2033Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 19, 2033Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
US Department of Justice
Cerilliant
Boehringer Ingelheim
Cantor Fitzgerald
Baxter
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.